1 Min Read
Feb 12 (Reuters) - Actinium Pharmaceuticals Inc:
* ACTINIUM ANNOUNCES SUBMISSION OF IND FOR ACTIMAB-A IN COMBINATION WITH CLAG-M FOR PATIENTS WITH RELAPSED OR REFRACTORY AML Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.